Amgen: earnings beats and dividend growth shift its investment story
FROM THE WIRE · FINANCE.YAHOO.COM
Amgen recently reported a 10% rise in second quarter revenue, continued to beat earnings and sales estimates, and maintained a dividend yield of 2.5% with annual increases of 8% from 2020 to 2025. The combination of consistent estimate beats, modest upward earnings revisions and…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralSolid quarterly results and dividend policy matter to investors, though they give no clear price impulse.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Amgen reported a 10% rise in second quarter revenue and continued to beat estimates.
- 02The dividend yield is 2.5%, with annual increases of 8% from 2020 to 2025.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Amgen Inc.424.94 USDMarket closedtoday -1.75%Neutral Merck & Co., Inc.143.67 USDMarket closedtoday -1.56%Neutral
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets